1
Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc, REID Scott W, May 4, 2006: WO/2006/047516 (17 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


2
He Yun, Ellis David Archer, Anaclerio Beth Marie, Kuhen Kelli L, Wu Baogen, Jiang Tao: Quinolones with anti-hiv activity. Irm, He Yun, Ellis David Archer, Anaclerio Beth Marie, Kuhen Kelli L, Wu Baogen, Jiang Tao, MANN Jeffry S, May 6, 2004: WO/2004/037853 (12 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using quinolones and compounds related to quinolones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of proph ...


3
Wu Baogen, He Yun, Ngyuen Truc, Kuhen Kelli L, Ellis David Archer, Jiang Tao: Pyrrolidones with anti-hiv activity. Irm, Wu Baogen, He Yun, Ngyuen Truc, Kuhen Kelli L, Ellis David Archer, Jiang Tao, MANN Jeffry S, May 6, 2004: WO/2004/037784 (6 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using pyrrolidones and compounds related to pyrrolidones. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of p ...


4
He Yun, Jiang Tao, Kuhen Kelli L, Ellis David Archer, Wu Baogen, Wu Tom Yao Hsiang, Bursulaya Badry: Oxindoles with anti-hiv activity. Irm, The Scripps Research Institute, He Yun, Jiang Tao, Kuhen Kelli L, Ellis David Archer, Wu Baogen, Wu Tom Yao Hsiang, Bursulaya Badry, FITTING Thomas, May 6, 2004: WO/2004/037247 (2 worldwide citation)

The present invention relates to inhibition of viruses, e.g., HIV using oxindoles and compounds related to oxindoles. The invention further relates to methods for identifying and using agents, including small molecule chemical compositions that inhibit HIV in a cell; as well as to methods of prophyl ...


5
He Xiaohui, Yang Kunyong, Liu Hong, Ellis David Archer: Azolopyrimidines as inhibitors of cannabinoid 1 activity. Irm, He Xiaohui, Yang Kunyong, Liu Hong, Ellis David Archer, REID Scott W, October 25, 2007: WO/2007/120454 (2 worldwide citation)

The invention provides compounds of formula (Ia), (Ic), (Ig) and (Ik), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


6
Molteni Valentina, Li Xiaolin, Nabakka Juliet, Ellis David Archer, Anaclerio Beth, Saez Enrique, Wityak John: Compounds and compositions as lxr modulators. Irm, Molteni Valentina, Li Xiaolin, Nabakka Juliet, Ellis David Archer, Anaclerio Beth, Saez Enrique, Wityak John, REID Scott W, August 25, 2005: WO/2005/077124 (1 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of liver X receptors (LXRs).


7
Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc: Composes et compositions servant dinhibiteurs dactivite de recepteur cannabinoide de type 1, Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Irm, Fetherstonhaugh & Co, October 25, 2011: CA2581225

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


8
He Xiaohui, Yang Kunyong, Liu Hong, Ellis David Archer: Composes et compositions utilises comme inhibiteurs de lactivite du recepteur cannabinoide de type 1, Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Irm, Fetherstonhaugh & Co, May 24, 2011: CA2645967

The invention provides compounds of formula (Ia), (Ic), (Ig) and (Ik), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


9

10
He Xiaohui, Yang Kunyong, Liu Hong, Ellis David Archer: Azolopyrimidines as inhibitors of cannabinoid 1 activity. Irm, December 10, 2008: EP1999132-A1

The invention provides compounds of formula (Ia), (Ic), (Ig) and (Ik), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).